BRS1(FM2) - Cholinergic Function
(Attention, Learning & Working Memory Systems)
1. Mission & Overview
Mission
Sustain acetylcholine-supported cholinergic signalling so attention, working memory, and learning-focused cognitive precision remain well supplied.
Overview
Supports attention, working memory, and cognitive precision through the brain's cholinergic signalling system (acetylcholine-based communication between neurons). Dietary choline and related substrates help maintain the biochemical foundation for learning-focused brain activity.
- Supports acetylcholine synthesis from dietary choline for learning-focused brain activity.
- Contributes to attention and working-memory cholinergic signalling.
- Intersects phospholipid substrate pools relevant to membrane chemistry — Supporting BRS2.
2. Primary Biological Effects
↑ choline availability; ↑ acetylcholine synthesis support; ↑ cholinergic signalling context
3. Phenome Connections
These outcomes describe translational contexts for the FM as an integrated biological capacity. They are not single-mechanism treatment claims. Biology → Phenome Confidence reflects biological relevance to each outcome — not proof that diet or lifestyle alone will improve it. Evidence Confidence (below Key References) reflects how convincing the attached evidence is for the Biology → Phenome relationship on that row. FM confidence uplift: FM confidence may exceed that of any individual child PM only where multiple PMs converge on the same phenome and the integrated FM biology provides additional biological rationale (biological uplift) beyond the individual mechanisms.
These are three independent scores. They are not combined or averaged. A phenome can have Medium registry evidence while individual mechanism rows show different Biology → Phenome and Evidence scores.
1. Phenome Evidence Confidence (Phenome Registry only)
Question: How convincing is the foundational evidence that this phenome is a valid, well-defined functional construct — and that diet-relevant biology can plausibly connect to it?
Not a roll-up of Biology → Phenome Confidence or Evidence Confidence from Primary Mechanism page rows. Those are scored per mechanism; this score is assigned once per phenome at registry level.
Derived from foundational landmark evidence organised in up to three layers: construct validation, biology→phenome linkage, and nutrition→biology modulation. Each layer may include one or many landmark papers depending on registry review.
2. Biology → Phenome Confidence (Primary Mechanism page §3 rows)
Question: If this PM/FM biology were substantially impaired in isolation, how directly would that phenome be expected to suffer — within BRAIN architecture?
How it is derived: Reviewers read the PM/FM definition and biological function first — initially ignoring attached references and whether dietary intervention studies exist. References are reviewed only when scoring Evidence Confidence (below).
Score levels (the value shown on each row as Biology → Phenome Confidence):
- High — primary biological determinant (e.g. noradrenergic signalling → attention; GABA synthesis → calming tone)
- Medium — major contributory determinant, not the sole driver
- Low–Medium — established but indirect, modulatory, or one integrative step removed
- Low — distal, conditional, or weak biological coupling
“Not dietary treatment efficacy” means this score does not ask whether a diet or supplement treats the phenome. It asks whether the biology itself is architecturally relevant. Limited dietary RCT evidence belongs in Evidence Confidence, not here.
3. Evidence Confidence (Primary Mechanism page §3 rows)
Question: How convincing are the attached Key References on that specific row that this biology actually relates to this phenome?
How it is derived: Assigned after Biology → Phenome Confidence, by reviewing only the references on that PM/FM row. Judges whether refs support the relationship — not just mechanism or phenome in isolation.
- High — strong convergent human evidence directly linking mechanism biology to phenome variation
- Medium — multiple human lines supporting the relationship; may include one bridge study with an inferential step
- Low–Medium — convergent translational stack without direct mechanism↔phenome measurement on the row
- Low — mechanistic or preclinical only; mechanism and phenome supported separately but not bridged
Often equal to or lower than Biology → Phenome Confidence. Can occasionally be higher when outcome evidence is stronger than the mechanism's contributory role.
- Biology → Phenome Confidence: Low–Medium
- Synthesis: As an integrated cholinergic substrate state, dietary choline provision and acetylcholine synthesis support may intersect attention-relevant cholinergic biology in ADHD when meal-level choline-rich foods and cofactor context remain adequate; Johansson et al. (2013) link reduced muscarinic receptor binding to ADHD boys and Derbyshire and Maes (2023) review choline deficits across neurodevelopmental disorders including ADHD—without implying dietary choline as a standalone treatment.
- Key References:
- Evidence Confidence: Low–Medium
- Biology → Phenome Confidence: Medium
- Synthesis: Framework translation: cholinergic function as an integrated FM state may support working-memory and cognitive-precision contexts when acetylcholine substrate availability is maintained through habitual dietary choline patterns; primary FM evidence establishes substrate and food-matrix biology rather than direct cognitive-clarity outcome trials.
- Key References:
- Evidence Confidence: Low
4. Mechanistic Basis (Integrated FM Narrative)
Cholinergic function represents a framework-relevant biological state anchored principally by its sole primary mechanism.
4.1 Core Primary Mechanisms
- BRS1-FM2-PM5 — Acetylcholine Synthesis Support Supports attention, working memory, and cognitive precision by helping the brain convert dietary choline into acetylcholine (the principal cholinergic neurotransmitter).
4.2 Integrated Functional Narrative
Although BRS1(FM2) is principally operationalised through BRS1-FM2-PM5 — Acetylcholine Synthesis Support, the FM represents the broader cholinergic substrate state supporting attention-relevant signalling. Dietary choline provision and habitual meal patterns influence whether acetylcholine synthesis can sustain cholinergic tone across attention, working memory, and cognitive precision contexts [Derbyshire et al., 2023; Briguglio et al., 2018].
At the FM level, performance depends on repeated choline-rich food exposure and synthesis capacity rather than single-meal precursor spikes.
4.3 Suboptimal Function & Its Effects
Cholinergic function may weaken when dietary choline provision or acetylcholine synthesis support remain chronically inadequate.
Low-choline dietary patterns, restrictive eating, or meal matrices that displace choline-rich whole foods (eggs, fish roe, organ meats, legumes) may reduce substrate availability for acetylcholine synthesis. At the FM level, this may shift the system toward weaker cholinergic signalling context relevant to attention, working memory, and cognitive precision [Derbyshire et al., 2023].
These pressures may impair BRS1-FM2-PM5 — Acetylcholine Synthesis Support.
4.4 Evidence Highlights
Introduction/Summary
The evidence below supports why cholinergic function matters as an integrated FM state — mechanism-qualifying findings from child PM biology, not functional outcome or phenome claims.
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Suboptimal choline intakes are reported in population surveys, reinforcing dietary choline as a substrate requiring deliberate food-pattern coverage rather than assumed adequacy [Derbyshire et al., 2023].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Dietary neurotransmitter reviews identify choline and acetylcholine among food-matrix compounds with nervous-system relevance, though bioavailability requires context-specific interpretation [Briguglio et al., 2018].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Findings support dietary choline adequacy and meal-level exposure as modifiable substrate context rather than isolated precursor boluses [Derbyshire et al., 2023].
- Key References:
5. Connected Mechanisms
- BRS1-FM1-PM1 - Amino-Acid Availability & Prioritisation — amino-Acid Availability & Prioritisation
- BRS1-FM1-PM2 - LAT1 Competitive Transport Modulation — lAT1 Competitive Transport Modulation
- BRS2(FM1) — Methylation Cycle Efficiency — methylation Cycle Efficiency